当前位置:首页 - 行情中心 - 康弘药业(002773) - 财务分析 - 现金流量表

康弘药业

(002773)

  

流通市值:285.03亿  总市值:382.34亿
流通股本:6.87亿   总股本:9.21亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,569,837,866.61,208,720,347.24,786,194,043.993,649,309,553.09
  收到的税费返还--2,552,375.172,552,375.17
  收到其他与经营活动有关的现金78,317,067.0433,056,888.1359,335,931.3932,664,351.77
  经营活动现金流入小计2,648,154,933.641,241,777,235.334,848,082,350.553,684,526,280.03
  购买商品、接受劳务支付的现金137,231,441.8560,770,871.49371,551,364.07275,931,761.42
  支付给职工以及为职工支付的现金661,230,983.58368,316,172.691,186,324,970.01891,595,359.48
  支付的各项税费244,126,567.0799,124,228.43403,087,500.23299,525,767.83
  支付其他与经营活动有关的现金689,779,620.04280,488,066.281,475,243,678.51963,005,779.68
  经营活动现金流出小计1,732,368,612.54808,699,338.893,436,207,512.822,430,058,668.41
  经营活动产生的现金流量净额915,786,321.1433,077,896.441,411,874,837.731,254,467,611.62
二、投资活动产生的现金流量:
  收回投资收到的现金2,640,000,000-4,330,790,0002,110,790,000
  取得投资收益收到的现金8,353,588.76-47,711,305.6920,518,283.08
  处置固定资产、无形资产和其他长期资产收回的现金净额53,154.6618,814.36548,764348,378.87
  收到的其他与投资活动有关的现金600,000330,0001,014,000387,308.59
  投资活动现金流入小计2,649,006,743.42348,814.364,380,064,069.692,132,043,970.54
  购建固定资产、无形资产和其他长期资产支付的现金74,295,030.4947,274,476.51159,390,322.05117,580,731.72
  投资支付的现金5,305,000,0002,640,000,0004,330,790,0004,330,790,000
  支付其他与投资活动有关的现金430,000226,0001,940,000610,000
  投资活动现金流出小计5,379,725,030.492,687,500,476.514,492,120,322.054,448,980,731.72
  投资活动产生的现金流量净额-2,730,718,287.07-2,687,151,662.15-112,056,252.36-2,316,936,761.18
三、筹资活动产生的现金流量:
  吸收投资收到的现金29,342,742.5270,0006,748,052.16,747,149.4
  其中:子公司吸收少数股东投资收到的现金270,000270,000--
  筹资活动现金流入小计29,342,742.5270,0006,748,052.16,747,149.4
  分配股利、利润或偿付利息支付的现金552,673,862.4-349,396,302.52349,396,302.52
  支付其他与筹资活动有关的现金1,617,120.151,476,919.361,491,045.53549,221.36
  筹资活动现金流出小计554,290,982.551,476,919.36350,887,348.05349,945,523.88
  筹资活动产生的现金流量净额-524,948,240.05-1,206,919.36-344,139,295.95-343,198,374.48
四、汇率变动对现金及现金等价物的影响-2,359.72-366,606.53-246,263.46-746,257.11
五、现金及现金等价物净增加额-2,339,882,565.74-2,255,647,291.6955,433,025.96-1,406,413,781.15
  加:期初现金及现金等价物余额5,625,427,246.565,625,427,246.564,669,994,220.64,669,994,220.6
  期末现金及现金等价物余额3,285,544,680.823,369,779,954.965,625,427,246.563,263,580,439.45
补充资料:
  净利润721,864,033.83-1,177,008,069.02-
  资产减值准备1,199,917.99-1,943,889.29-
  固定资产和投资性房地产折旧99,096,017.62-197,382,035.6-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧99,096,017.62-197,382,035.6-
  无形资产摊销16,672,349.14-31,758,036.56-
  长期待摊费用摊销1,979,204.7-3,983,537.52-
  处置固定资产、无形资产和其他长期资产的损失-3,472.82--14,202.59-
  固定资产报废损失257,117.33-1,322,725.15-
  公允价值变动损失1,884,200-1,056,000-
  财务费用317,709.81-317,686.92-
  投资损失-8,123,311.62--47,277,710.26-
  递延所得税80,711,773.66-103,708,268.48-
  其中:递延所得税资产减少83,580,674.79-98,619,543.82-
    递延所得税负债增加-2,868,901.13-5,088,724.66-
  存货的减少12,793,834.18-13,789,722.46-
  经营性应收项目的减少-33,799,903.82--45,745,744.42-
  经营性应付项目的增加17,438,381.06--30,378,010.37-
  其他2,600,399.42-1,746,476.54-
  现金的期末余额3,285,544,680.82-5,625,427,246.56-
  减:现金的期初余额5,625,427,246.56-4,669,994,220.6-
  现金及现金等价物的净增加额-2,339,882,565.74-955,433,025.96-
公告日期2025-08-282025-04-262025-04-262024-10-25
审计意见(境内)标准无保留意见
TOP↑